Alcon (ALC) Stock Price, News & Analysis

Company Overview

Alcon Inc. (NYSE: ALC) is a global eye care company that develops, manufactures and markets products for eye care professionals and consumers. Its business is organized primarily around Surgical and Vision Care, serving ophthalmologists, optometrists, surgeons and patients worldwide.

The company’s Surgical portfolio includes equipment, instruments, implantable products and other technologies used in cataract, retinal, refractive and other ophthalmic procedures. Its Vision Care business offers contact lenses, contact lens care products and over-the-counter eye care products designed to support vision correction and ocular health.

Alcon traces its origins to an ophthalmic business founded in Fort Worth, Texas, in 1945. It later became part of Novartis before being spun off as an independent, publicly traded company in 2019. Alcon serves customers in numerous markets across the Americas, Europe, Asia and other regions, and is led by Chief Executive Officer David J. Endicott.

Key Stats

• Today's Range: $65.02 to $66.41
• 50-Day Range: $62.96 to $75.25
• 52-Week Range: $61.83 to $87.64
• Volume: 635,258 shs
• Average Volume: 1.85 million shs
• Market Capitalization: $32.87 billion
• P/E Ratio: 50.76
• Dividend Yield: N/A
• Price Target: $83.39
• Consensus Rating: Moderate Buy

Alcon Stock Analysis - MarketRank™

Alcon scored higher than 81% of companies evaluated by MarketBeat, and ranked 105th out of 873 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Alcon has received a consensus rating of Moderate Buy. The company's average rating score is 2.63, and is based on 1 strong buy rating, 11 buy ratings, 6 hold ratings, and 1 sell rating.

Upside Potential

Alcon has a consensus price target of $83.39, representing about 30.5% upside from its current price of $63.91.

Amount of Analyst Coverage

Alcon has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 12.00%

Earnings Growth

Earnings for Alcon are expected to grow by 12.00% in the coming year, from $3.50 to $3.92 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Alcon is 19.33, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 36.70.

Price to Earnings Ratio vs. Sector

The P/E ratio of Alcon is 19.33, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 223.62.

Price to Earnings Growth Ratio

Alcon has a PEG Ratio of 1.90. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Alcon has a P/B Ratio of 1.43. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

3.67% of the float of Alcon has been sold short.

Short Interest Ratio / Days to Cover

Alcon has a short interest ratio ("days to cover") of 9.35.

Change versus previous month

Short interest in Alcon has recently increased by 2.22%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.8 / 5
• Dividend Strength: N/A

Dividend Yield

Alcon does not currently pay a dividend.

Dividend Growth

Alcon has only been increasing its dividend for 4 years.

Dividend Sustainability

Based on earnings estimates, Alcon will have a dividend payout ratio of 8.42% next year. This indicates that Alcon will be able to sustain or increase its dividend.

News and Social Media

• Score: 2.0 / 5
• News Sentiment: 0.15

News Sentiment

Alcon has a news sentiment score of 0.15. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.71 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Alcon this week, compared to 5 articles on an average week.

Search Interest

Only 1 people have searched for ALC on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

MarketBeat Follows

2 people have added Alcon to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Alcon insiders have not sold or bought any company stock.

Percentage Held by Insiders

1.52% of the stock of Alcon is held by insiders.

Percentage Held by Institutions

53.86% of the stock of Alcon is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/10/2026
• Today: 10/15/2026
• Next Earnings (Estimated): 11/10/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Supplies
• Current Symbol: NYSE:ALC
• CIK: 1167379
• Web: www.alcon.com
• Phone: 418172930450
• Fax: 41-58-911-3222
• Employees: 25,942
• Year Founded: 1945

Price Target and Rating

• Average Price Target for Alcon: $83.39
• High Price Target: $101.09
• Low Price Target: $70.00
• Potential Upside/Downside: +25.5%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.63
• Research Coverage: 19 Analysts

Profitability

• EPS (Trailing Twelve Months): $1.31
• Trailing P/E Ratio: 50.70
• Forward P/E Ratio: 18.99
• P/E Growth: 1.9
• Net Income: $980 million
• Net Margins: 5.92%
• Pretax Margin: 6.82%
• Return on Equity: 7.29%
• Return on Assets: 5.09%

Debt

• Debt-to-Equity Ratio: 0.19
• Current Ratio: 2.09
• Quick Ratio: 1.30

Sales & Book Value

• Annual Sales: $10.40 billion
• Price / Sales: 3.16
• Cash Flow: $5.78 per share
• Price / Cash Flow: 11.49
• Book Value: $44.55 per share
• Price / Book: 1.49

Miscellaneous

• Outstanding Shares: 494,620,000
• Free Float: 487,098,000
• Market Cap: $32.87 billion
• Optionable: Optionable
• Beta: 0.88